-
Lords call for clarity on EU healthcare deal
pharmatimes
July 20, 2018
The House of Lords EU Committee is urging the government to clarify the reciprocal healthcare arrangements for UK citizens in the EU and EU citizens in the UK post Brexit.
-
UK Government announces £10m antimicrobial resistance research competition
pharmafile
July 17, 2018
The UK Government’s Department of Health and Social Care has announced the launch of a £10 million research competition aimed at combatting antimicrobial resistance (AMR) as part of its five year antimicrobial resistance strategy.
-
UK and Irish regulators recall valsartan drugs over impurity concerns
pharmaceutical-technology
July 12, 2018
UK and Irish regulatory authorities have recalled all batches of valsartan containing drugs manufactured by Dexcel Pharma and Accord Healthcare, previously known as Actavis Group.
-
UK IVF regulator issues new guidelines on costly add-ons
pharmaceutical-technology
July 12, 2018
The UK’s fertility regulator the Human Fertilisation and Embryology Authority’s (HFEA) updated code of practice mandates that fertility clinics inform IVF patients if the expensive add-on treatments they are being offered have been not proven to be effect
-
The July/August issue of Pharmafocus is now live!
pharmafile
July 06, 2018
As cross- and inter-party squabbles ramp up and negotiations become ever more weighted with ominous importance, the day the UK will officially exit the European Union grows ever closer.
-
UK’s genome sequencing project will hit 100,000 by year-end
pharmatimes
July 05, 2018
Genomics England says the 100,000 Genomes Project is “well on track” to reach its target of sequencing 100,000 genomes by the end of this year.
-
UK Space Agency links with NHS England to find health innovations
pharmatimes
July 04, 2018
The UK Space Agency will stream up to £4 million into find hi-tech solutions to major health and care challenges facing the NHS in its 70th anniversary year, under a joint initiative with NHS England.
-
Aptamer Group: UK Biotech Business Raises $2.2M Investment
b3cnewswire
July 04, 2018
Rapidly growing biotech business, Aptamer Group Ltd, has closed its Series A investment round after attracting international interest, securing $2.2m of funding from overseas investors to support its pioneering aptamer development programme.
-
Piramal subsidiary sells stake in PISA to UK’s Alliance Medical Acquisitionco
financialexpress
June 29, 2018
Total consideration for this sale is base consideration of $1 plus $ 1,177,682 towards working capital adjustment on completion of the sale
-
Study shows almost half of UK women experience ‘serious trouble’ with contraception
pharmaceutical-technology
June 28, 2018
A study by educational women’s health website Femedic records that 47% of women in the UK have had ‘serious trouble’ with their current or previous form of contraception and 16% said they did not receive adequate professional care when they were experienc